DIA Biosimilars 2013

Campbell Alliance

Campbell Alliance launches market research and analytics group

Wednesday, March 21, 2012 11:42 AM

Campbell Alliance, an inVentiv Health company and management consulting firm, has launched Encuity Research, the firm's market research and analytics subsidiary.

More... »

Cenduit: Now with Patient Reminders

inVentiv Health to acquire SDI businesses from IMS Health

Friday, January 20, 2012 02:53 PM

Burlington, Mass.-based inVentiv Health will acquire certain promotional and medical audit businesses of SDI Health, which IMS Health has committed to divest in connection with obtaining regulatory approval of its acquisition of SDI.  Financial terms were not disclosed.

More... »

CRF Health – eCOA Forum

inVentiv Health buys i3 divisions, Campbell Alliance, allowing it to compete with CRO industry’s big players

Monday, January 31, 2011 08:00 AM

Ingenix, a UnitedHealth Group subsidiary that provides health care information to the managed care and drug development sectors, is selling off its clinical trial management and contract research services. Those holdings include i3 Research, i3 Statprobe and i3 Pharma Resourcing. 

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs